Russell Investments Group
KITE

Russell Investments Group’s Kite Pharma, Inc. KITE Stock Holding History

Russell Investments Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,478
Closed -$266K – 3085
2017
Q3 		$266K Sell
1,478
-27,151
-95% -$3.78M ﹤0.01% 2611
2017
Q2 		$2.97M Sell
28,629
-1,977
-6% -$161K 0.01% 1504
2017
Q1 		$2.4M Buy
30,606
+12,909
+73% +$798K ﹤0.01% 1651
2016
Q4 		$801K Buy
+17,697
New +$868K ﹤0.01% 2285

Russell Investments Group's KITE Position: Q4 2017 in Review

Russell Investments Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,478 shares — an estimated $266K sold.

Russell Investments Group first reported a position in KITE in Q4 2016 and held it in 4 quarters. The position peaked at $2.97M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Russell Investments Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Russell Investments Group sold 1,478 Kite Pharma, Inc. shares in Q4 2017, an estimated $266K.
  • Russell Investments Group first reported a position in Kite Pharma, Inc. in Q4 2016 and held it in 4 quarters.
  • Russell Investments Group's Kite Pharma, Inc. position peaked at $2.97M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Russell Investments Group's 13F filing for Q4 2017, filed 6 Feb 2018.